Contact Us

Leading GSK-3 Implications Globaally

GSKure uses the novel SCI strategy for drug design that has a significant advantage for clinical practice.
Professor Hagit Eldar-Finkelman, from Tel Aviv University, conducted pioneering studies in developing GSK-3
inhibitors and the therapeutic use in treating human disease.

Join Our Effort

GSKure ia an IP based company dedicated to implicate its theraprotic approach for treating brain desires.
To enhance our mission we are in search for partners to join our efforts.

  • Philanthropy
  • Biotech enerpenuers
  • Government

Contact Us

Contact Us